GlassScriptPhysician profile
Anna Vielweber
NPI 1801640438
$1,708.73
in general payments reported to CMS, 2019-2025
18 companies · $1,568 in 2025
The $1,568 reported for 2025 was more than what 91% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $140 · 2025: $1,568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,059 · Travel and Lodging: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,059.06 |
| Travel and Lodging | $649.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $949.51 | 2025 | Minimed 780g |
| Abbvie INC. | $164.68 | 2024-2025 | |
| Recordati_rare_diseases_inc. | $111.43 | 2024-2025 | Isturisa, Signifor Lar |
| Lilly USA, LLC | $104.53 | 2025 | |
| Dexcom, INC. | $54.19 | 2024-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $40.24 | 2025 | Freestyle Libre 3 |
| Sequel Med Tech, LLC | $30.46 | 2025 | Twiist |
| Genzyme Corporation | $29.72 | 2025 | |
| Xeris Pharmaceuticals, INC. | $28.57 | 2024 | Recorlev |
| Ucb, INC. | $27.03 | 2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $25.97 | 2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $24.32 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $23.00 | 2024 | Arcalyst |
| Glaxosmithkline, LLC. | $20.63 | 2025 | Benlysta |
| Globus Medical, INC. | $20.54 | 2025 | Senza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $19.13 | 2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.93 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $15.85 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Vielweber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.